{"entity":{"type":"insider","cik":"0001720634","url":"/insider/0001720634","json_url":"/insider/0001720634.json","name":"Grossi Federico","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":42,"first":"2020-06-16","last":"2023-01-09","span_basis":"filed_date"},"name_variants":[{"name":"Grossi Federico","source":"filing","n_filings":42,"first_seen":"2020-06-16","last_seen":"2023-01-09"}],"transactions":[{"id":8225432,"accession":"0001127602-23-001182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-001182","line_url":"/filing/0001127602-23-001182#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":48.79,"price_display":"48.79","price_state":"stated","total_value":121975.0,"total_display":"121,975.00","total_whole":"121,975","shares_owned_after":94884.0,"shares_owned_after_display":"94,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":6264623,"accession":"0000899243-22-037437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-037437","line_url":"/filing/0000899243-22-037437#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":49.93,"price_display":"49.93","price_state":"stated","total_value":124825.0,"total_display":"124,825.00","total_whole":"124,825","shares_owned_after":97384.0,"shares_owned_after_display":"97,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":6089890,"accession":"0000899243-22-034914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034914","line_url":"/filing/0000899243-22-034914#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":60.83,"price_display":"60.83","price_state":"stated","total_value":152075.0,"total_display":"152,075.00","total_whole":"152,075","shares_owned_after":99884.0,"shares_owned_after_display":"99,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6600410,"accession":"0001127602-22-023728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-023728","line_url":"/filing/0001127602-22-023728#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":66.69,"price_display":"66.69","price_state":"stated","total_value":166725.0,"total_display":"166,725.00","total_whole":"166,725","shares_owned_after":102384.0,"shares_owned_after_display":"102,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6963701,"accession":"0001127602-22-022000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-022000","line_url":"/filing/0001127602-22-022000#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":60.3,"price_display":"60.30","price_state":"stated","total_value":150750.0,"total_display":"150,750.00","total_whole":"150,750","shares_owned_after":104884.0,"shares_owned_after_display":"104,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-02","scope":"insider"},{"id":6270441,"accession":"0001127602-22-020150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-020150","line_url":"/filing/0001127602-22-020150#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":55.99,"price_display":"55.99","price_state":"stated","total_value":139975.0,"total_display":"139,975.00","total_whole":"139,975","shares_owned_after":107384.0,"shares_owned_after_display":"107,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-02","scope":"insider"},{"id":6816850,"accession":"0001127602-22-016470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-016470","line_url":"/filing/0001127602-22-016470#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":41.78,"price_display":"41.78","price_state":"stated","total_value":104450.0,"total_display":"104,450.00","total_whole":"104,450","shares_owned_after":109561.0,"shares_owned_after_display":"109,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6929677,"accession":"0001127602-22-013110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-013110","line_url":"/filing/0001127602-22-013110#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":43.56,"price_display":"43.56","price_state":"stated","total_value":108900.0,"total_display":"108,900.00","total_whole":"108,900","shares_owned_after":112061.0,"shares_owned_after_display":"112,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":6463463,"accession":"0001127602-22-009795","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-009795","line_url":"/filing/0001127602-22-009795#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":39.57,"price_display":"39.57","price_state":"stated","total_value":14838.75,"total_display":"14,838.75","total_whole":"14,839","shares_owned_after":116436.0,"shares_owned_after_display":"116,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"},{"id":6703073,"accession":"0001127602-22-007825","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-007825","line_url":"/filing/0001127602-22-007825#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":43.53,"price_display":"43.53","price_state":"stated","total_value":16323.75,"total_display":"16,323.75","total_whole":"16,324","shares_owned_after":109811.0,"shares_owned_after_display":"109,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":6681454,"accession":"0001127602-22-005299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-005299","line_url":"/filing/0001127602-22-005299#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":45.43,"price_display":"45.43","price_state":"stated","total_value":17036.25,"total_display":"17,036.25","total_whole":"17,036","shares_owned_after":106086.0,"shares_owned_after_display":"106,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":6576246,"accession":"0001127602-22-002980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-002980","line_url":"/filing/0001127602-22-002980#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":40.58,"price_display":"40.58","price_state":"stated","total_value":15217.5,"total_display":"15,217.50","total_whole":"15,218","shares_owned_after":103566.0,"shares_owned_after_display":"103,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-02","scope":"insider"},{"id":6531854,"accession":"0000899243-22-002519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-002519","line_url":"/filing/0000899243-22-002519#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":40.56,"price_display":"40.56","price_state":"stated","total_value":15210.0,"total_display":"15,210.00","total_whole":"15,210","shares_owned_after":78540.0,"shares_owned_after_display":"78,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-19","scope":"insider"},{"id":6649002,"accession":"0001127602-22-000422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-000422","line_url":"/filing/0001127602-22-000422#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":47.31,"price_display":"47.31","price_state":"stated","total_value":17741.25,"total_display":"17,741.25","total_whole":"17,741","shares_owned_after":70354.0,"shares_owned_after_display":"70,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":4857574,"accession":"0001127602-21-031428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-031428","line_url":"/filing/0001127602-21-031428#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":42.88,"price_display":"42.88","price_state":"stated","total_value":16080.0,"total_display":"16,080.00","total_whole":"16,080","shares_owned_after":70729.0,"shares_owned_after_display":"70,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":4889539,"accession":"0001127602-21-030234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-030234","line_url":"/filing/0001127602-21-030234#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":42.4,"price_display":"42.40","price_state":"stated","total_value":15900.0,"total_display":"15,900.00","total_whole":"15,900","shares_owned_after":64104.0,"shares_owned_after_display":"64,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":4134569,"accession":"0001127602-21-029468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-029468","line_url":"/filing/0001127602-21-029468#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":43.5,"price_display":"43.50","price_state":"stated","total_value":27187.5,"total_display":"27,187.50","total_whole":"27,188","shares_owned_after":64479.0,"shares_owned_after_display":"64,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":4778915,"accession":"0001127602-21-028064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-028064","line_url":"/filing/0001127602-21-028064#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":30.7,"price_display":"30.70","price_state":"stated","total_value":19187.5,"total_display":"19,187.50","total_whole":"19,188","shares_owned_after":64805.0,"shares_owned_after_display":"64,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-02","scope":"insider"},{"id":5214384,"accession":"0001127602-21-027119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-027119","line_url":"/filing/0001127602-21-027119#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":34.57,"price_display":"34.57","price_state":"stated","total_value":25927.5,"total_display":"25,927.50","total_whole":"25,928","shares_owned_after":65430.0,"shares_owned_after_display":"65,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-15","scope":"insider"},{"id":4593087,"accession":"0001127602-21-026674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-026674","line_url":"/filing/0001127602-21-026674#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":33.26,"price_display":"33.26","price_state":"stated","total_value":24945.0,"total_display":"24,945.00","total_whole":"24,945","shares_owned_after":66180.0,"shares_owned_after_display":"66,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":5510380,"accession":"0001127602-21-022943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-022943","line_url":"/filing/0001127602-21-022943#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":63.99,"price_display":"63.99","price_state":"stated","total_value":15997.5,"total_display":"15,997.50","total_whole":"15,998","shares_owned_after":62930.0,"shares_owned_after_display":"62,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":4215559,"accession":"0001127602-21-022018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-022018","line_url":"/filing/0001127602-21-022018#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":64.68,"price_display":"64.68","price_state":"stated","total_value":32340.0,"total_display":"32,340.00","total_whole":"32,340","shares_owned_after":63180.0,"shares_owned_after_display":"63,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-15","scope":"insider"},{"id":4733797,"accession":"0001127602-21-021745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-021745","line_url":"/filing/0001127602-21-021745#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":65.68,"price_display":"65.68","price_state":"stated","total_value":16420.0,"total_display":"16,420.00","total_whole":"16,420","shares_owned_after":63680.0,"shares_owned_after_display":"63,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider"},{"id":5004317,"accession":"0001127602-21-019900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-019900","line_url":"/filing/0001127602-21-019900#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":61.84,"price_display":"61.84","price_state":"stated","total_value":30920.0,"total_display":"30,920.00","total_whole":"30,920","shares_owned_after":54930.0,"shares_owned_after_display":"54,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-15","scope":"insider"},{"id":4777163,"accession":"0001127602-21-017174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-017174","line_url":"/filing/0001127602-21-017174#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":45.39,"price_display":"45.39","price_state":"stated","total_value":22695.0,"total_display":"22,695.00","total_whole":"22,695","shares_owned_after":55430.0,"shares_owned_after_display":"55,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":4733095,"accession":"0001127602-21-015183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-015183","line_url":"/filing/0001127602-21-015183#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":50.73,"price_display":"50.73","price_state":"stated","total_value":30438.0,"total_display":"30,438.00","total_whole":"30,438","shares_owned_after":55614.0,"shares_owned_after_display":"55,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-04","scope":"insider"},{"id":4132748,"accession":"0001127602-21-013755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-013755","line_url":"/filing/0001127602-21-013755#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":42.82,"price_display":"42.82","price_state":"stated","total_value":21410.0,"total_display":"21,410.00","total_whole":"21,410","shares_owned_after":56214.0,"shares_owned_after_display":"56,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-15","scope":"insider"},{"id":5108316,"accession":"0001127602-21-013176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-013176","line_url":"/filing/0001127602-21-013176#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":43.41,"price_display":"43.41","price_state":"stated","total_value":26046.0,"total_display":"26,046.00","total_whole":"26,046","shares_owned_after":56714.0,"shares_owned_after_display":"56,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":4590799,"accession":"0001127602-21-011026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-011026","line_url":"/filing/0001127602-21-011026#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":46.77,"price_display":"46.77","price_state":"stated","total_value":23385.0,"total_display":"23,385.00","total_whole":"23,385","shares_owned_after":57314.0,"shares_owned_after_display":"57,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":5346959,"accession":"0001127602-21-009693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-009693","line_url":"/filing/0001127602-21-009693#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.615,"price_display":"48.62","price_state":"stated","total_value":243075.0,"total_display":"243,075.00","total_whole":"243,075","shares_owned_after":57814.0,"shares_owned_after_display":"57,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":5461218,"accession":"0001127602-21-009097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-009097","line_url":"/filing/0001127602-21-009097#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":48.58,"price_display":"48.58","price_state":"stated","total_value":29148.0,"total_display":"29,148.00","total_whole":"29,148","shares_owned_after":57814.0,"shares_owned_after_display":"57,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":4460352,"accession":"0001127602-21-006150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-006150","line_url":"/filing/0001127602-21-006150#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":46.0,"price_display":"46.00","price_state":"stated","total_value":23000.0,"total_display":"23,000.00","total_whole":"23,000","shares_owned_after":58414.0,"shares_owned_after_display":"58,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":5142682,"accession":"0001127602-21-003484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-003484","line_url":"/filing/0001127602-21-003484#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":26400.0,"total_display":"26,400.00","total_whole":"26,400","shares_owned_after":59602.0,"shares_owned_after_display":"59,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider"},{"id":5441741,"accession":"0001127602-21-001756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-001756","line_url":"/filing/0001127602-21-001756#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":51.99,"price_display":"51.99","price_state":"stated","total_value":207960.0,"total_display":"207,960.00","total_whole":"207,960","shares_owned_after":35827.0,"shares_owned_after_display":"35,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-15","scope":"insider"},{"id":5405021,"accession":"0001127602-21-000523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-000523","line_url":"/filing/0001127602-21-000523#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":57.24,"price_display":"57.24","price_state":"stated","total_value":34344.0,"total_display":"34,344.00","total_whole":"34,344","shares_owned_after":39827.0,"shares_owned_after_display":"39,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":2408742,"accession":"0001127602-20-030293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-030293","line_url":"/filing/0001127602-20-030293#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":48.25,"price_display":"48.25","price_state":"stated","total_value":28950.0,"total_display":"28,950.00","total_whole":"28,950","shares_owned_after":33177.0,"shares_owned_after_display":"33,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-02","scope":"insider"},{"id":2408415,"accession":"0001127602-20-027991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-027991","line_url":"/filing/0001127602-20-027991#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.09,"price_display":"31.09","price_state":"stated","total_value":18654.0,"total_display":"18,654.00","total_whole":"18,654","shares_owned_after":27725.0,"shares_owned_after_display":"27,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":3137990,"accession":"0001127602-20-026264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-026264","line_url":"/filing/0001127602-20-026264#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":30.22,"price_display":"30.22","price_state":"stated","total_value":18132.0,"total_display":"18,132.00","total_whole":"18,132","shares_owned_after":28325.0,"shares_owned_after_display":"28,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":2176758,"accession":"0001127602-20-024640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-024640","line_url":"/filing/0001127602-20-024640#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.58,"price_display":"31.58","price_state":"stated","total_value":18948.0,"total_display":"18,948.00","total_whole":"18,948","shares_owned_after":28925.0,"shares_owned_after_display":"28,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-02","scope":"insider"},{"id":2428471,"accession":"0001127602-20-022885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-022885","line_url":"/filing/0001127602-20-022885#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":15768.0,"total_display":"15,768.00","total_whole":"15,768","shares_owned_after":29525.0,"shares_owned_after_display":"29,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2145128,"accession":"0001127602-20-021048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-021048","line_url":"/filing/0001127602-20-021048#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850.0,"shares_display":"850","price_per_share":32.43,"price_display":"32.43","price_state":"stated","total_value":27565.5,"total_display":"27,565.50","total_whole":"27,566","shares_owned_after":30125.0,"shares_owned_after_display":"30,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2746835,"accession":"0001127602-20-019735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-019735","line_url":"/filing/0001127602-20-019735#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001720634","owner_name":"Grossi Federico","owner_display_name":"Grossi Federico","owner_url":"/insider/0001720634","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":856.0,"shares_display":"856","price_per_share":30.21,"price_display":"30.21","price_state":"stated","total_value":25859.76,"total_display":"25,859.76","total_whole":"25,860","shares_owned_after":30975.0,"shares_owned_after_display":"30,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":42,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (Chief Medical Officer)","n_filings":42,"first_seen":"2020-06-16","last_seen":"2023-01-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001720634","retrieved_at":"2026-08-23T08:45:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}